MedDataX Logo

Combined Diagnosis of CT and Exosome in Early Lung Cancer

NCT ID: NCT03542253

Last Updated: 2018-05-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-20

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This experiment has now collected 50 cases, all through CT chest scans and blood exosome detection. Twenty-two patients underwent surgical treatment and 14 tissue specimens were examined for cancer and paracancerous tissue exosomesWe found that exosomal micor-A was highly expressed in early stage lung cancer tissues and was significantly higher than paracancerous tissues. The micor-A in the adjacent tissues was significantly higher than that in peripheral blood exosomes

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Lung Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Early lung cancer,ground-glass nodule,CT,exosome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Age

No interventions assigned to this group

Sex

No interventions assigned to this group

triglyceride

No interventions assigned to this group

Lipoprotein

No interventions assigned to this group

CT

Target Reconstruction

No interventions assigned to this group

micorRNA-A Plasma exocrine

No interventions assigned to this group

micorRNA-A Paracancerous tiusse

No interventions assigned to this group

pathologic diagnosis

Surgery

Intervention Type PROCEDURE

After surgical treatment, pathological specimens were extracted to obtain pathological results

hemolysis

No interventions assigned to this group

ct-DNA

No interventions assigned to this group

micorRNA-A in plasma

No interventions assigned to this group

Sample quality control

No interventions assigned to this group

positive

No interventions assigned to this group

negative

No interventions assigned to this group

micorRNA-R in plasma

No interventions assigned to this group

micorRNA-R in Plasma exocrine

No interventions assigned to this group

Surgery

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgery

After surgical treatment, pathological specimens were extracted to obtain pathological results

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\-

Exclusion Criteria

\-
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital of Soochow University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

gongjianping

Combined diagnosis of CT and exosome in early lung cancer

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

123456

Identifier Type: -

Identifier Source: org_study_id